According to Zydus Lifesciences's latest financial reports and stock price the company's current Operating Margin is 27.66%. At the end of 2024 the company had an Operating Margin of 25.28%.
Year | Operating Margin | Change |
---|---|---|
2024 | 25.28% | 64.77% |
2023 | 15.34% | -19.84% |
2022 | 19.14% | 12.69% |
2021 | 16.99% | 56.88% |
2020 | 10.83% | -42.06% |
2019 | 18.69% | -7.16% |
2018 | 20.13% | 14.27% |
2017 | 17.61% | -20.89% |
2016 | 22.26% | 30.87% |
2015 | 17.01% | 27.47% |
2014 | 13.35% | 1.58% |
2013 | 13.14% | -15.8% |
2012 | 15.60% | -17.31% |
2011 | 18.87% | 11.68% |
2010 | 16.90% | 33.76% |
2009 | 12.63% | -11.49% |
2008 | 14.27% | -6.96% |
2007 | 15.34% | 25.4% |
2006 | 12.23% | 10.91% |
2005 | 11.03% | -12.91% |
2004 | 12.67% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.